BiotechTubeBiotechTube
Home/Pipeline/Oligonucleotide APIs

Oligonucleotide APIs

Various

Clinical/CommercialActive development

Key Facts

Indication
Various
Phase
Clinical/Commercial
Status
Active development
Company
Bachem

About Bachem

Founded in 1971 and headquartered in Switzerland, Bachem has evolved from a specialized peptide laboratory into a global leader in TIDES manufacturing with over 1,200 employees worldwide. The company operates through an integrated platform covering clinical development, GMP manufacturing, and custom synthesis services for both peptides and oligonucleotides. With facilities in Switzerland, the US, and subsidiaries globally, Bachem serves as a trusted manufacturing partner to pharmaceutical and biotech companies developing innovative therapeutic products.

View full company profile

Therapeutic Areas

Multiple therapeutic areas via CDMO servicesMultiple SclerosisVarious pharmaceutical applications

Other Various Drugs

DrugCompanyPhase
Biosimilar ProgramsRichter GedeonPhase 3
Novel Plasma-derived TherapiesTiantan BioPre-clinical
Complex Injectable Generics PipelineAmphastar PharmaceuticalsANDA Filed / Development
Generic PortfolioStrides PharmaApproved
New Product LaunchesFDC IndiaDevelopment/Filing
Generic Products PortfolioCelon PharmaApproved/Commercial
New Generic Filings (e.g., for US/EU)Bliss GVS PharmaRegulatory Review
Pipeline of Complex GenericsMayne Pharma GroupDevelopment
Bag APIsChemWerthApproved
Oral APIsChemWerthApproved